Jason A. Segreti

1.4k total citations
20 papers, 552 citations indexed

About

Jason A. Segreti is a scholar working on Molecular Biology, Physiology and Nephrology. According to data from OpenAlex, Jason A. Segreti has authored 20 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Physiology and 2 papers in Nephrology. Recurrent topics in Jason A. Segreti's work include Nitric Oxide and Endothelin Effects (3 papers), Adipose Tissue and Metabolism (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Jason A. Segreti is often cited by papers focused on Nitric Oxide and Endothelin Effects (3 papers), Adipose Tissue and Metabolism (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). Jason A. Segreti collaborates with scholars based in United States, United Kingdom and France. Jason A. Segreti's co-authors include Ryan M. Fryer, Bryan F. Cox, James S. Polakowski, Patricia N. Banfor, D. L. Widomski, Philip R. Kym, Glenn A. Reinhart, Stephen J. Ballaron, B. F. Cox and James M. Trevillyan and has published in prestigious journals such as Brain Research, Free Radical Biology and Medicine and Journal of Medicinal Chemistry.

In The Last Decade

Jason A. Segreti

20 papers receiving 536 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jason A. Segreti United States	15	163	142	84	66	65	20	552
Peter Ochodnický Netherlands	18	187 1.1×	261 1.8×	134 1.6×	138 2.1×	99 1.5×	30	953
Jianfang Liu China	11	127 0.8×	150 1.1×	51 0.6×	27 0.4×	58 0.9×	17	499
Masashi Tawa Japan	14	112 0.7×	199 1.4×	235 2.8×	51 0.8×	39 0.6×	59	512
Zhaohui Pei China	18	462 2.8×	200 1.4×	102 1.2×	72 1.1×	83 1.3×	38	889
Nuria Villalba United States	16	234 1.4×	83 0.6×	167 2.0×	105 1.6×	60 0.9×	34	694
Ibra S. Fancher United States	15	189 1.2×	164 1.2×	215 2.6×	33 0.5×	51 0.8×	38	583
Kenro Imaeda Japan	13	174 1.1×	130 0.9×	235 2.8×	100 1.5×	110 1.7×	37	591
Alisson Martins-Oliveira Brazil	14	68 0.4×	139 1.0×	161 1.9×	51 0.8×	56 0.9×	18	511
Stephanie M. Mutchler United States	15	386 2.4×	133 0.9×	211 2.5×	88 1.3×	48 0.7×	33	689
Taiji Nagata Japan	12	117 0.7×	106 0.7×	91 1.1×	23 0.3×	27 0.4×	24	346

Countries citing papers authored by Jason A. Segreti

Since Specialization

Citations

This map shows the geographic impact of Jason A. Segreti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason A. Segreti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason A. Segreti more than expected).

Fields of papers citing papers by Jason A. Segreti

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason A. Segreti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason A. Segreti. The network helps show where Jason A. Segreti may publish in the future.

Co-authorship network of co-authors of Jason A. Segreti

This figure shows the co-authorship network connecting the top 25 collaborators of Jason A. Segreti. A scholar is included among the top collaborators of Jason A. Segreti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason A. Segreti. Jason A. Segreti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Watson, Mark A., Hoi Shan Wong, Pratiksha Dighe, et al.. (2023). Suppression of superoxide/hydrogen peroxide production at mitochondrial site IQ decreases fat accumulation, improves glucose tolerance and normalizes fasting insulin concentration in mice fed a high-fat diet. Free Radical Biology and Medicine. 204. 276–286. 7 indexed citations

Lynch, James J., Emilie Rossignol, Joerg J. Moehrle, et al.. (2019). Increased stress associated with head-out plethysmography testing can exacerbate respiratory effects and lead to mortality in rats. Journal of Pharmacological and Toxicological Methods. 99. 106580–106580. 5 indexed citations

Segreti, Jason A., James S. Polakowski, Eric A.G. Blomme, & Andrew J. King. (2016). Simultaneous measurement of arterial and left ventricular pressure in conscious freely moving rats by telemetry. Journal of Pharmacological and Toxicological Methods. 79. 23–33. 9 indexed citations

Gomtsyan, Arthur, Heath A. McDonald, Robert G. Schmidt, et al.. (2015). TRPV1 ligands with hyperthermic, hypothermic and no temperature effects in rats. Temperature. 2(2). 297–301. 21 indexed citations

Segreti, Jason A., Kennan C. Marsh, Joy Bauch, et al.. (2010). Tumour‐selective antivascular effects of the novel anti‐mitotic compound A‐318315: Anin vivorat regional haemodynamic study. Clinical and Experimental Pharmacology and Physiology. 37(5-6). 636–640. 3 indexed citations

King, Andrew, Jason A. Segreti, Andrew J. Souers, et al.. (2010). In vivo efficacy of acyl CoA: Diacylglycerol acyltransferase (DGAT) 1 inhibition in rodent models of postprandial hyperlipidemia. European Journal of Pharmacology. 637(1-3). 155–161. 28 indexed citations

Wu-Wong, J. Ruth, William T. Noonan, Masaki Nakane, et al.. (2010). Vitamin D Receptor Activation Mitigates the Impact of Uremia on Endothelial Function in the 5/6 Nephrectomized Rats. International Journal of Endocrinology. 2010. 1–10. 37 indexed citations

King, Andrew, Jason A. Segreti, Andrew J. Souers, et al.. (2009). Diacylglycerol Acyltransferase 1 Inhibition Lowers Serum Triglycerides in the Zucker Fatty Rat and the Hyperlipidemic Hamster. Journal of Pharmacology and Experimental Therapeutics. 330(2). 526–531. 40 indexed citations

Banfor, Patricia N., Jason A. Segreti, D. L. Widomski, et al.. (2009). ETA Receptor Blockade With Atrasentan Prevents Hypertension With the Multitargeted Tyrosine Kinase Inhibitor ABT-869 in Telemetry-instrumented Rats. Journal of Cardiovascular Pharmacology. 53(2). 173–178. 35 indexed citations

10.

Banfor, Patricia N., Paul Tapang, Jason A. Segreti, et al.. (2009). Effect of the Multitargeted Receptor Tyrosine Kinase Inhibitor, ABT-869 [N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N′-(2-fluoro-5-methylphenyl)urea], on Blood Pressure in Conscious Rats and Mice: Reversal with Antihypertensive Agents and Effect on Tumor Growth Inhibition. Journal of Pharmacology and Experimental Therapeutics. 329(3). 928–937. 16 indexed citations

11.

McGaraughty, Steve, Jason A. Segreti, Ryan M. Fryer, et al.. (2009). Antagonism of TRPV1 receptors indirectly modulates activity of thermoregulatory neurons in the medial preoptic area of rats. Brain Research. 1268. 58–67. 27 indexed citations

12.

Segreti, Jason A., Kennan C. Marsh, James S. Polakowski, & Ryan M. Fryer. (2008). Evoked Changes in Cardiovascular Function in Rats by Infusion of Levosimendan, OR-1896 [(R)-N-(4-(4-Methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl)acetamide], OR-1855 [(R)-6-(4-Aminophenyl)-5-methyl-4,5-dihydropyridazin-3(2 H)-one], Dobutamine, and Milrinone: Comparative Effects on Peripheral Resistance, Cardiac Output, dP/dt, Pulse Rate, and Blood Pressure. Journal of Pharmacology and Experimental Therapeutics. 325(1). 331–340. 32 indexed citations

13.

Fryer, Ryan M., Jason A. Segreti, D. L. Widomski, et al.. (2007). Systemic Activation of the Calcium Sensing Receptor Produces Acute Effects on Vascular Tone and Circulatory Function in Uremic and Normal Rats: Focus on Central versus Peripheral Control of Vascular Tone and Blood Pressure by Cinacalcet. Journal of Pharmacology and Experimental Therapeutics. 323(1). 217–226. 24 indexed citations

14.

Fryer, Ryan M., Jason A. Segreti, Patricia N. Banfor, et al.. (2007). Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin‐mediated angioedema. British Journal of Pharmacology. 153(5). 947–955. 105 indexed citations

15.

Polakowski, James S., Jason A. Segreti, Bryan F. Cox, et al.. (2004). Effects of selective dopamine receptor subtype agonists on cardiac contractility and regional haemodynamics in rats. Clinical and Experimental Pharmacology and Physiology. 31(12). 837–841. 29 indexed citations

16.

Randolph, John T., Daryl R. Sauer, Fortuna Haviv, et al.. (2004). Nonpeptide Luteinizing Hormone-Releasing Hormone Antagonists Derived from Erythromycin A: Design, Synthesis, and Biological Activity of Cladinose Replacement Analogues. Journal of Medicinal Chemistry. 47(5). 1085–1097. 22 indexed citations

17.

Luo, Yanping, Vincent P. Hradil, Jerry L. Wessale, et al.. (2002). Evaluation of tissue perfusion in a rat model of hind‐limb muscle ischemia using dynamic contrast‐enhanced magnetic resonance imaging. Journal of Magnetic Resonance Imaging. 16(3). 277–283. 34 indexed citations

18.

Besecke, Leslie M., Gilbert Diaz, Jason A. Segreti, et al.. (2001). Pharmacological and endocrine characterization of A‐198401, an orally active GnRH antagonist, in intact and castrate male rat models. Drug Development Research. 52(3). 485–491. 14 indexed citations

19.

Cowles, Verne E., H N Nellans, Terese Seifert, et al.. (2000). Effect of Novel Motilide ABT-229 versus Erythromycin and Cisapride on Gastric Emptying in Dogs. Journal of Pharmacology and Experimental Therapeutics. 293(3). 1106–1111. 22 indexed citations

20.

Segreti, Jason A., Gilles Gheusi, Robert Dantzer, Keith W. Kelley, & Rodney W. Johnson. (1997). Defect in Interleukin-1β Secretion Prevents Sickness Behavior in C3H/HeJ Mice. Physiology & Behavior. 61(6). 873–878. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact